%0 Journal Article
%T Pharmacological characterization of a novel potent, selective, and orally active phosphodiesterase 10A inhibitor, PDM©\042 [(E)©\4©\(2©\(2©\(5,8©\dimethyl©\[1,2,4]triazolo[1,5©\a]pyrazin©\2©\yl)vinyl)©\6©\(pyrrolidin©\1©\yl)pyrimidin©\4©\yl)morpholine] in rats: potential for the treatment of schizophrenia
%A Hiroyasu Naba
%A Kazunari Nakao
%A Keita Arakawa
%A Makoto Ishikawa
%A Natsuko Yuge
%A Shunsuke Maehara
%A Yutaka Kato
%A Yutaka Miyazaki
%J Archive of "Pharmacology Research & Perspectives".
%D 2016
%R 10.1002/prp2.241
%K Antipsychotics
%K catalepsy
%K occupancy
%K PDE10A
%K PDM©\042
%K schizophrenia
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242175/